DMSO 5 10 20 HA (BMP2) MG-132 (µM) GAPDH NT Ponceau S BMP2 Cell Lysate Supernatant A) 240 360 480 Ponceau S BMP2 Time (min) B) Supernatant Epox -+ -+ -+ Blocking of proteasomal degradation pathway with MG-132 leads to an increase in BMP2 level and enhances secretion Supplementary Figure 1 A) 293T cells were transfected with a mammalian expression vector encoding BMP2. The cells were split 24 hours post-transfection and treated with indicated dose of MG-132. The cells were harvested and media from cells was collected 6 hours post treatment. Intracellular BMP-2 level (upper panel) and secreted BMP-2 level (lower panel) was determined by immunoblotting.
Sphere model of BMP2 showed that the indicated lysine residues (shown in blue) form a cluster adjacent to the cleavage site (shown in green) that releases mature BMP2. All structure figures are generated using PyMol Supplementary Table 1 : Primers used for construction of K-to-R mutants of BMP-2
BMP-2 Mutation
Mutagenesis Primer Sequence
F 5'-GACGAGAATGAAAAGGTTGTATTAAGGAACTATCAGGACATGG-3' R5'-CCATGTCCTGATAGTTCCTTAATACAACCTTTTCAttTTCTCGTC-3'
